Definium Therapeutics, Inc.
DFTX- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001813814
In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Definium Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 156 | 3 | 175 | +22 |
| Shares | 37.8M | 37.0K | 44.7M | +6.88M (+18.2%) |
| Value | $131.0M | $127.0K | $104.8M | −$26.1M (−19.9%) |
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (40)
Institutions that held Definium Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (18)
Institutions that held Definium Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| UBS Asset Management Americas Inc | 163,000 | $567.3K |
| HAP Trading, LLC | 68,055 | $235.0K |
| Two Sigma Advisers, LP | 43,500 | $150.0K |
| MYDA Advisors LLC | 30,000 | $104.0K |
| Engineers Gate Manager LP | 17,144 | $59.0K |
| Point72 Hong Kong Ltd | 16,821 | $58.0K |
| EP Wealth Advisors, LLC | 12,292 | $42.0K |
| Resources Investment Advisors, LLC. | 11,675 | $40.0K |
| Raymond James Financial Services Advisors, Inc. | 10,541 | $36.0K |
| Clear Street Markets LLC | 10,000 | $35.0K |
| Optimum Investment Advisors | 8,000 | $28.0K |
| Pinz Capital Management, LP | 6,200 | $21.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 5,171 | $18.0K |
| HHM Wealth Advisors, LLC | 725 | $3.00K |
| Anfield Capital Management, LLC | 550 | $2.00K |
| Glen Eagle Advisors, LLC | 433 | $1.51K |
| FMR LLC | 1 | $0 |
| Ford Financial Group, LLC | 200 | $0 |
Not filed for Q3 2021 yet (3)
Institutions that held Definium Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 20,900 | $72.0K |
| Pictet Asset Management Ltd | 15,700 | $54.0K |
| Hoover Financial Advisors, Inc. | 404 | $1.00K |